Hensley Mark Earl sold HRTX
October 30, 2026 · Form 4 insider transaction
Hensley Mark Earl sold 3,349 shares of Heron Therapeutics, Inc. at $0.28 per share, a transaction worth $937.72. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,349
Price
$0.28
Total value
$937.72
InsiderHensley Mark Earl
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after179,322
OwnershipDirect
10b5-1 planNo
AmendedNo